Year archive

Middle East Pharmaceutical Industries Co. — 2024 filings

All 11 regulatory filings released by Middle East Pharmaceutical Industries Co. (4016) in 2024, sourced directly from the official regulator.

11 Filings

2024 Period

2024 filings (11)

Filing	Released	Lang
Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2024-09-30 ( Nine Months ) Interim / Quarterly Report 9M 2024	2024-11-07	English
Middle East Pharmaceutical Industries Co. Announces Obtaining Bank facilities compatible with the provisions of Islamic Sharia Capital/Financing Update	2024-11-04	English
Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2024-06-30 ( Six Months ) Interim / Quarterly Report H1 2024	2024-08-05	English
Middle East Pharmaceutical Industries Co. Announces Obtaining Banking facilities compatible with the provisions of Islamic Sharia Capital/Financing Update	2024-08-01	English
Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for The first half of 2024 Notice of Dividend Amount	2024-07-30	English
Middle East Pharmaceutical Industries Co. Announces Obtaining Bank facilities compatible with the provisions of Islamic Sharia Capital/Financing Update	2024-07-09	English
Middle East Pharmaceutical Industries Co. Announces the Results of the Extraordinary General Assembly Meeting, ( First Meeting ) Declaration of Voting Results & Voting Rights Announcements	2024-07-01	English
The Board of Directors of Middle East Pharmaceutical Industries Co. invites shareholders to Attend the Extraordinary General Assembly Meeting (First Meeting) through Modern Means of Technology AGM Information	2024-06-09	English
Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months ) Interim / Quarterly Report Q1 2024	2024-05-19	English
Middle East Pharmaceutical Industries Company “Avalon Pharma” announces the approval of the Saudi Food and Drug Authority (SFDA) to register new production lines at the company's Factory No. 2 in Riya Regulatory Filings	2024-05-06	English
Middle East Pharmaceutical Industries Co. announces its Annual Financial results for the period ending on 2023-12-31 Earnings Release FY 2023	2024-03-25	English